Clinical trial
Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk…
NCT00098800 · University of Arizona, Other · Completed
Key facts
| NCT number | NCT00098800 |
|---|---|
| Title | Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries |
| Official title | A Multicenter Randomized Double-Blinded Trial for Chemoprevention of Ovarian Cancer: Modulation of Biomarkers and Spectral Properties Using Contrast Enhanced Ultrasound in High-Risk Women Using Fenretinide (4-HPR) |
| Lead sponsor | University of Arizona, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | brca1 Mutation Carrier, brca2 Mutation Carrier, Ovarian Cancer |
| Intervention type | Drug |
| Interventions | fenretinide |
| Enrollment | 40 |
| Start date | Oct 1, 2004 |
| Primary completion | Aug 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Dec 9, 2004 |
| Last update posted | Mar 24, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: